Bristol-Myers Squibb Provides Update on Part 2 of CheckMate -227 - Yahoo Finance

Bristol-Myers Squibb Provides Update on Part 2 of CheckMate -227  Yahoo Finance

PRINCETON, N.J.-- -- Study Did Not Meet Its Primary Endpoint of Overall Survival with Opdivo ® Plus Chemotherapy vs. Chemotherapy in First-Line ...